Poddar, A.; Ahmady, F.; Rao, S.R.; Sharma, R.; Kannourakis, G.; Prithviraj, P.; Jayachandran, A. The Role of Pregnancy Associated Plasma Protein-A in Triple Negative Breast Cancer: A Promising Target for Achieving Clinical Benefits. Journal of Biomedical Science 2024, 31, doi:10.1186/s12929-024-01012-x.
Poddar, A.; Ahmady, F.; Rao, S.R.; Sharma, R.; Kannourakis, G.; Prithviraj, P.; Jayachandran, A. The Role of Pregnancy Associated Plasma Protein-A in Triple Negative Breast Cancer: A Promising Target for Achieving Clinical Benefits. Journal of Biomedical Science 2024, 31, doi:10.1186/s12929-024-01012-x.
Poddar, A.; Ahmady, F.; Rao, S.R.; Sharma, R.; Kannourakis, G.; Prithviraj, P.; Jayachandran, A. The Role of Pregnancy Associated Plasma Protein-A in Triple Negative Breast Cancer: A Promising Target for Achieving Clinical Benefits. Journal of Biomedical Science 2024, 31, doi:10.1186/s12929-024-01012-x.
Poddar, A.; Ahmady, F.; Rao, S.R.; Sharma, R.; Kannourakis, G.; Prithviraj, P.; Jayachandran, A. The Role of Pregnancy Associated Plasma Protein-A in Triple Negative Breast Cancer: A Promising Target for Achieving Clinical Benefits. Journal of Biomedical Science 2024, 31, doi:10.1186/s12929-024-01012-x.
Abstract
Pregnancy associated plasma protein-A (PAPP-A) plays an integral role in breast cancer (BC), especially triple negative breast cancer (TNBC). This subtype accounts for the most aggressive BC, possesses high tumor heterogeneity, is least responsive to standard treatments and has the poorest clinical outcomes. There is a critical need to address the lack of effective targeted therapeutic options available. PAPP-A is a protein that is highly elevated during pregnancy. Frequently, higher PAPP-A expression is detected in tumors than in healthy tissues. The increase in expression coincides with increased rates of aggressive cancers. In BC, PAPP-A has been demonstrated to play a role in tumor initiation, progression, metastasis including epithelial-mesenchymal transition (EMT), as well as acting as a biomarker for predicting patient outcomes. In this review, we present the role of PAPP-A, with specific focus on TNBC. The structure and function of PAPP-A, belonging to the pappalysin subfamily, and its proteolytic activity are assessed. We highlight the link of BC and PAPP-A with respect to the IGFBP/IGF axis, EMT, the window of susceptibility and the impact of pregnancy. Importantly, the relevance of PAPP-A as a TNBC clinical marker is reviewed and its influence on immune-related pathways are explored. The relationship and mechanisms involving PAPP-A reveal the potential for more treatment options that can lead to successful immunotherapeutic targets and the ability to assist with better predicting clinical outcomes in TNBC.
Keywords
pregnancy associated plasma protein-A; breast cancer; triple negative breast cancer; epithelial-mesenchymal transition; cancer therapy; cancer biomarker; immunotherapy
Subject
Biology and Life Sciences, Biology and Biotechnology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
